Cantargia utvecklar en antikroppsbaserad behandling riktad mot målmolekylen IL1RAP som har potential att användas för ett flertal olika cancersjukdomar.
Member count: 11-50
Total raised: $1.035925M
Founded date: 2010
Investors 1
| Date | Name | Website |
| - | Ideon Scie... | ideon.se |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 05.07.2013 | - | $1.035925M | - | finsmes.co... |
Mentions in press and media 79
| Date | Title | Description | Category | Author | Source |
| 21.11.2022 | Nomination... | Nomination Committee appointed... | - | - | news.cisio... |
| 10.11.2022 | Cantargia ... | Cantargia publishes interim re... | - | - | news.cisio... |
| 08.11.2022 | Cantargia’... | Cantargia’s CAN10 demonstrates... | - | - | news.cisio... |
| 07.11.2022 | Cantargia ... | Cantargia presents new data at... | - | - | news.cisio... |
| 28.10.2022 | Invitation... | Invitation to presentation of ... | - | - | news.cisio... |
| 15.09.2022 | Cantargia:... | Cantargia: Oral presentation o... | - | - | news.cisio... |
| 13.09.2022 | Cantargia ... | Cantargia presents preclinical... | - | - | news.cisio... |
| 31.08.2022 | New number... | New number of shares and votes... | - | - | news.cisio... |
| 30.08.2022 | Cantargia ... | Cantargia publishes half year ... | - | - | news.cisio... |
| 30.08.2022 | Cantargia ... | Cantargia publishes preclinica... | - | - | news.cisio... |
Show more